Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

Conditions:   Cancer of the Prostate;   Castration-resistant Prostate Cancer
Intervention:   Drug: Gadoxetate Sodium
Sponsor:   University of Cincinnati
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffAggressive | Biomarker | Cancer | Enhanced | Gadoxetate | Prostate | Sodium
Comments